ModifiedPremera BluecrossPolicy 1.04.05

Orthoses for the Lower Limb

Defines medical necessity, investigational and not-covered stances, device HCPCS, and clinical selection criteria for microprocessor-controlled and powered knee and ankle-foot prostheses for individuals with lower-limb amputation.

Policy Summary

PayerPremera Bluecross

PolicyOrthoses for the Lower Limb

Policy CodePolicy 1.04.05

Change TypeCoding addition (L2221) and administrative update

Effective Date04/01/2026

Next Review DateJun 1, 2026

Key ActionObtain prior authorization for listed HCPCS when requesting microprocessor-controlled or powered knee/ankle-foot devices.

SourceLink

POLICY UPDATE CHANGES

New HCPCS addition code L2221 for microprocessor-controlled ankle system effective 04/01/26 is listed.

Replaces prior policies 1.01.25, 1.01.513 and 1.04.05 and lists updates dated Jun. 1, 2026 May 11, 2026.

L2006, L2221, L5615-L5973HCPCS codes listed

InsufficientEvidence for powered knee/ankle

400 yardsDaily ambulation threshold

K0–K4K-levels referenced

06/01/26Policy history through

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria and Evidence Stance

Microprocessor-controlled knee (medical necessity)

Microprocessor-controlled knee (medical necessity) — ALL criteria required for transfemoral amputee candidacy

ALL of the following

Demonstrated need for long-distance ambulation at variable rates (use of the limb in the home or for basic community ambulation is not sufficient to justify provision of the computerized limb over standard limb applications).
OR: Demonstrated individual need for regular ambulation on uneven terrain or for regular use on stairs (use of the limb for limited stair climbing in the home or employment environment is not sufficient evidence for prescription of this device over standard prosthetic application).
Physical ability, including adequate cardiovascular and pulmonary reserve, for ambulation at faster than normal walking speed.
Adequate cognitive ability to master use and care requirements for the technology.

Investigational devices/technologies

Investigational — list of devices/technologies considered investigational

ANY of the following

Powered knee prostheses (e.g., HCPCS L5827, L5859) - considered investigational due to insufficient evidence of improved functional outcomes compared with microprocessor-controlled knees or standard knees.
Microprocessor-controlled or powered ankle-foot prostheses (e.g., HCPCS L5969, L5973) - considered investigational; limited evidence does not demonstrate improved functional outcomes versus standard prostheses.

Not Covered Additions

Not Covered Additions — ANY of the following makes additions to conventional prosthesis not covered

ANY of the following

Used only for recreational, sports, or athletic activities.
Available over-the-counter or off-the-shelf without a prescription from the treating physician or consultation with a prosthetist.

Microprocessor knee — evidence summary

Microprocessor knee prostheses — evidence-based stance summarizing net health outcome conclusions

ALL of the following

For K3- and K4-level (Medicare) transfemoral amputees, studies show objective improvement in function on some measures (e.g., hill and ramp descent) and strong patient preference for microprocessor-controlled knees, with benefits including more normal gait, increased stability, and decreased falls.
For K2 ambulators, prostheses with stance control only can improve activities requiring balance and walking in this population; appropriate physical and cognitive ability is required to realize benefit.

Powered knee — evidence summary

Powered knee prostheses — evidence-based stance (not proven to improve outcomes vs microprocessor knees)

ALL of the following

Available evidence includes small within-subject comparisons (n<10) and does not demonstrate improved functional outcomes with powered knee prostheses compared with microprocessor-controlled knees.
No studies identified directly comparing powered knees with standard prosthetic knees in transfemoral amputation; evidence is insufficient to determine improvement in net health outcome.

Ankle‑foot prostheses — evidence stance

Microprocessor and powered ankle-foot prostheses — evidence stance (limited/insufficient)

ALL of the following

Evidence for microprocessor-controlled ankle-foot prostheses is limited and does not consistently show improved functional outcomes versus standard prostheses; one small study noted quality of life improvements but overall evidence is insufficient.
Evidence for powered ankle-foot prostheses is limited and does not demonstrate improved functional outcomes compared with standard prostheses; evidence is insufficient to determine improvement in net health outcome.

Microprocessor stance‑controlled KAFOs — evidence stance

Microprocessor stance‑controlled KAFOs (C‑Brace/Sensor Walk) — evidence stance (limited/insufficient)

ALL of the following

For individuals with neuromuscular lower-limb deficits using microprocessor stance-controlled KAFOs (e.g., Ottobock C‑Brace, Sensor Walk), evidence is limited to small, nonrandomized studies with methodological limitations and potential conflicts of interest.
Available studies suggest possible improvements in activities of daily living (ambulation at varying speeds, descending stairs) compared with prior orthoses, but limitations (small sample sizes, lack of randomization/blinding, nonvalidated self-reported measures) preclude definitive conclusions.

Document clinical justification for K-level and demonstrate that contraindications are absent when considering microprocessor-controlled knees.

Benefit or contract language limiting durable medical equipment upgrades may affect coverage; document cost-effectiveness and comparative outcome data when requesting higher-cost devices.

Historical policy notes reflect that powered knee and powered/microprocessor ankle-foot devices have been considered investigational in prior reviews when evidence did not demonstrate improved outcomes.

Ensure documentation demonstrates all required criteria before approving a microprocessor-controlled knee; absence of any criterion supports a determination of not medically necessary.

These technologies are considered investigational pending stronger evidence of clinical benefit.

Refer to historical policy entries for context on the development of current medical necessity criteria.

HCPCS and FDA Codes

HCPCS codes listedHCPCS

L2006	Knee-ankle-foot (KAF) device, any material, single or double upright, swing and/or stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated (e.g., C-Brace Orthotronic Mobility System)
L2221	Addition to lower extremity orthosis, ankle system, microprocessor-controlled feature plantarflexion and/or dorsiflexion, includes power source (new code effective 04/01/26)
L5615	Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control (when used as an additional component to a microprocessor- controlled knee)
L5827	Endoskeletal knee-shin system, single axis, electromechanical swing and stance phase control, with or without shock absorption and stance extension damping (use to report: Power Knee, Ossur Americas, Inc.)
L5856	Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type.
L5857	Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type.
L5858	Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type.
L5859	Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s).
L5969	Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s).
L5973	Endoskeletal ankle foot system, microprocessor-controlled feature, dorsiflexion and/or plantar flexion control, includes power source

FDA product codesmixed

ISW	FDA product code for certain microprocessor-controlled prostheses
KFX	FDA product code for certain microprocessor-controlled prostheses

KAFO FDA product codesmixed

IQI	FDA product code for Sensor Walk electronic stance control KAFO

FDA product codesmixed

ISW	FDA product code for microprocessor-controlled prostheses
KFX	FDA product code for microprocessor-controlled prostheses
IQI	FDA product code for Sensor Walk electronic stance control KAFO

HCPCS codes referenced in history/coding updatesHCPCS

L5615	HCPCS code added (coding update referenced)
L5969	HCPCS code added (coding update referenced)
L5827	HCPCS code added (coding update referenced)
L2221	HCPCS code added effective April 1, 2026 (coding update referenced)
K1014	HCPCS code previously added/termed (history notes)
L2006	HCPCS code added (history notes)

inv-20: Daily continuous ambulation — example threshold used in clinical documentation (metric)

Example daily ambulation thresholdAt least 400 continuous yards of daily ambulation

Context for threshold useUsed to document need for long‑distance ambulation at variable cadence or terrain as part of clinical justification for microprocessor knees

Typical requirementDaily and frequent ambulation of two or more activities (e.g., variable cadence, uneven terrain, stairs) usually needed to show benefit

Prior Authorization, Documentation, and Billing Guidance

Prior Authorization

Prior Authorization Required

Prior authorization is required for HCPCS-coded microprocessor or powered prosthetic devices and related additions when benefit language requires prior review. Submit prior authorization requests with supporting clinical documentation and relevant HCPCS codes.

Prior authorization may be required by the member's benefit plan or contract.
Verify any prior authorization requirements with the payer before ordering or fabricating the device.

Prior Authorization

Verify Benefits and Prior Authorization

Before ordering microprocessor-controlled or powered prosthetic components, providers should verify member benefits and any prior authorization requirements. Benefit booklets and customer service determine coverage limits, least-cost alternative rules, and whether upgrades are covered.

Confirm whether durable medical equipment/prosthesis upgrades are covered under the member's contract.
Ask customer service for limits, frequency, or exclusions that may apply to microprocessor devices.

Background and Scope

Microprocessor-controlled prosthetic knees incorporate sensors and onboard computing to regulate swing and stance phases with the goal of producing a more natural gait, improving stability (for example during hill or ramp descent), and reducing falls. Selection for use depends on demonstrated functional need (long-distance or variable-speed ambulation, regular uneven-terrain walking, or regular stair use), as well as adequate physical ability including cardiovascular and pulmonary reserve, and sufficient cognitive function to manage device operation and care.

Key Definitions

inv-34: Hydraulic system — definition and clinical note

DefinitionHydraulic system: pistons inside cylinders containing fluid (usually silicone oil) that respond to a wide range of walking speeds to provide gait control

Clinical noteProduces gait patterns close to normal knee function, is heavier than pneumatic systems, and can be added to mechanical or microprocessor prostheses — suitable for more active individuals

Use caseCan be integrated with mechanical or computerized knees to provide improved stance/swing control across variable speeds

inv-35: Microprocessor prosthesis — definition

DefinitionMicroprocessor prosthesis: a prosthetic joint that receives feedback from internal sensors and uses an internal computer to adjust flexion, extension, and speed to mimic the user's natural gait

Mechanism

Policy Revision History

01/01/24coding_update

Added HCPCS code L5615 and updated term for HCPCS code K1014 (coding update).

04/01/24coding_clarification

Interim review added a clarifying coding note and definition of terms regarding use of addition components on other prostheses.

06/01/24coding_update

Added HCPCS code L5969 (coding update).

Policy Summary

PayerPremera Bluecross

PolicyOrthoses for the Lower Limb

Policy CodePolicy 1.04.05

Change TypeCoding addition (L2221) and administrative update

Effective Date04/01/2026

Next Review DateJun 1, 2026

Key ActionObtain prior authorization for listed HCPCS when requesting microprocessor-controlled or powered knee/ankle-foot devices.

SourceLink

On This Page

Prior Authorization

Verify Benefits and Obtain Prior Authorization

Obtain prior authorization when the member's benefit or contract requires it. Prior authorization decisions are guided by medical necessity criteria in this policy, but coverage is ultimately governed by the member's benefit language.

Provide documentation that all medical necessity criteria are met when requesting authorization (see required clinical documentation).
If benefits describe a "least costly alternative," include justification or evidence of trial/failure of lower-cost options when applicable.

Denial Risk

Cost/Benefit Denial Risk

When a microprocessor-controlled device is substantially more costly than available alternatives and evidence does not show superior outcomes, the device may be denied as not medically necessary under the Plan's definition and/or per the plan's least costly alternative provision.

Document why the microprocessor device is clinically necessary and why lower-cost alternatives are not appropriate.
Be aware that lack of evidence of superior outcomes for newer microprocessor models increases denial risk for higher-cost devices.

Denial Risk

Denial Trigger for Unmet Criteria

If the member does not meet ALL required clinical criteria for a microprocessor-controlled knee (long-distance variable-speed ambulation OR regular ambulation on uneven terrain/stairs, adequate cardiovascular/pulmonary reserve, and adequate cognitive ability), the request will be considered not medically necessary and may be denied.

Use documentation to demonstrate long-distance variable-speed ambulation needs or regular uneven terrain/stair use; household or basic community ambulation alone is insufficient.
Document physical and cognitive ability to safely use the technology.

Documentation Required

Device Classification and Custom-Fit Documentation

Document device classification, custom fabrication, and fit. For microprocessor stance/swing KAFOs (e.g., C‑Brace) and custom-fit devices, include evidence of custom fabrication and fitting, device model, and rationale for custom device.

Report the appropriate HCPCS code that matches the device and whether it is custom fabricated (e.g., L2006 for microprocessor KAFO, L5856/L5857/L5858/L5859 for microprocessor knee features, L5969/L5973 for ankle-foot additions).
Include manufacturer's model, proof of custom fabrication, and description of components (sensors, batteries, charger) when applicable.

Documentation Required

Benefit Verification and Documentation

Providers must verify benefit limits, frequency, and exclusions in the member's benefit booklet or by contacting customer service. Coverage for medical services is subject to the limits and conditions of the member's benefit plan.

Consult the member benefit booklet or customer service to confirm coverage for prosthetic upgrades and additions.
Confirm whether the policy applies under the member's plan (this policy does not apply to Medicare Advantage).

Note

Trial with Standard Prosthesis Recommended

When potential benefit is uncertain, consider trialing a standard prosthesis before providing a microprocessor-controlled knee or KAFO. Document the trial, functional outcomes, and why the microprocessor device is necessary if the standard prosthesis is inadequate.

Record functional assessment results with the standard prosthesis and rationale for escalation to a microprocessor device.
If benefit language requires trial of a less costly alternative, include documentation of trial failure or insufficiency.

Prior Authorization

Least Costly Alternative Considerations

If the member's contract contains a "least costly alternative" provision, providers should justify use of higher‑cost microprocessor devices by documenting why lower‑cost alternatives are inappropriate or have been tried and failed.

Include comparative rationale and trial documentation when requesting authorization for a higher‑cost device.
Be prepared to show that alternative mechanical or non-microprocessor devices did not meet functional needs.

Documentation Required

Required Clinical Documentation

Providers: ensure all required clinical documentation accompanies requests — demonstration of long‑distance variable‑speed ambulation OR regular uneven terrain/stair need; evidence of adequate cardiovascular/pulmonary reserve; and cognitive ability to manage the device. Missing documentation may delay or result in denial.

Attach objective functional assessments, clinical notes, and patient-reported activity needs.
If requesting additions to non-microprocessor prostheses, verify policy applicability and supply appropriate codes and rationale.

Internal computer controls the mechanical mechanism which may be single axis, pneumatic, or hydraulic

Functional capabilityCan control both swing and stance phases based on sensor inputs

inv-36: Powered prosthesis — definition

DefinitionPowered prosthesis: a motor‑activated prosthesis that uses sensors to control and generate flexion and extension movements to imitate biomechanical function of the missing limb

MechanismUses onboard motors together with sensor feedback to actively produce joint movement rather than relying solely on passive mechanical elements

Comparative noteIntended to replace muscle activity by actively generating movement, distinct from microprocessor control which modulates passive mechanisms

inv-37: Hydraulic system (alternate entry) — piston/fluid description for gait control

DescriptionPistons inside air‑filled cylinders that compress air during flexion, storing energy and returning it during extension (pneumatic control)

Comparative noteProvides better swing control than friction knees but is considered less effective than hydraulic systems; generally lighter than hydraulics

ApplicationCan be used as part of mechanical prostheses to improve swing-phase dynamics

inv-38: Pneumatic system — definition and comparative note

DefinitionPneumatic system: pistons inside cylinders containing air that compress during flexion to store and return energy during extension

Performance noteBetter swing control than friction knees but less effective than hydraulic systems

Weight/behavioral noteTypically lighter than hydraulic systems and used to improve swing-phase control in mechanical prostheses

inv-39: Microprocessor prosthesis (alternate entry) — sensor-feedback description

DescriptionMicroprocessor prosthesis receives feedback from sensors and other parameters inside the joint to adjust flexion, extension, and speed via an internal computer

Sensor roleSensors provide real‑time input used by the internal computer to modulate the mechanical mechanism for swing and stance control

IntegrationCan be combined with pneumatic or hydraulic mechanical components under computer control

inv-40: Powered prosthesis (alternate entry) — motor-activated definition

DefinitionPowered prosthesis: motor‑activated device that uses sensors to generate and control flexion and extension movements

Operational noteSensors guide motor output to imitate biomechanical function and actively produce joint movement rather than only modulate passive elements

Clinical implicationDesigned to replace lost muscle-generated movement and provide active assistance during gait

inv-41: C‑Brace (Microprocessor KAFO) — device description and custom classification

Device descriptionC‑Brace: a custom microprocessor stance and swing control KAFO with continuous knee flexion and angular acceleration sensing, hydraulic resistances, rechargeable lithium‑ion battery, and app control

Regulatory/classification noteManufacturer and FDA classify the C‑Brace as a Class I medical device and it is custom made for each individual

Clinical purposeIntended to increase mobility in individuals with leg paresis and to allow more natural movement on stairs, inclines, and rough terrain

inv-42: K-Level — CMS functional classification definition (K0–K4)

DefinitionK‑Level (CMS): Rehabilitation potential classification K0–K4 describing ability/potential to ambulate and functional demand for a prosthesis

K‑Level examplesK0: no ability to ambulate; K1: household ambulator; K2: limited community ambulator; K3: community ambulator with variable cadence; K4: exceeds basic ambulation (athlete/active adult)

Clinical useK‑Level informs candidacy for microprocessor knees (typically K3–K4 for greatest benefit)

inv-43: FDA class I — regulatory classification definition and implication

DefinitionFDA class I: regulatory classification for low‑risk devices that are exempt from 510(k) premarket notification and require only manufacturer notification prior to marketing

ImplicationClass I status means clinical efficacy data are not required by FDA for market notification, but manufacturers must notify the FDA before marketing

RelevanceMany microprocessor‑controlled prostheses and devices like the C‑Brace are described as FDA Class I in the policy

04/01/25coding_update

Added new HCPCS code L5827 (coding update).

04/01/26coding_update

Added new HCPCS code L2221, effective April 1, 2026 (coding update).

06/01/25annual_review

Annual review with literature update through February 5, 2025; policy statements unchanged (annual review entry).

02/10/04policy_creation

Policy added to Durable Medical Equipment section (new policy PR.1.01.113 replacing prior policy).

05/13/08policy_replacement

New BC policy replacing PR.1.01.513; microprocessor-controlled knee described as may be considered medically necessary (historical policy statement).

06/01/16annual_review

Annual review approved May 10, 2016; literature search with no change to policy statement.

03/01/20interim_review

Interim review with literature search; policy title changed and statement added that microprocessor stance-controlled orthoses are investigational; HCPCS code L2006 added effective 01/01/20.

06/01/20policy_number_change

New policy number (1.04.503) approved May 5, 2020; replaced policy 1.04.05 (policy updated with literature review, statements unchanged).

06/01/21annual_review

Annual review approved May 4, 2021; literature update through January 25, 2021; policy statements unchanged.

06/01/22annual_review

Annual review approved May 9, 2022; literature update through January 24, 2022; added HCPCS code K1014; policy statements unchanged.

06/01/23annual_review

Annual review approved May 5, 2023; literature update through January 26, 2023; policy statements unchanged.

01/01/24coding_update

Coding update added HCPCS code L5615 and updated term for K1014.

06/01/24annual_review

Annual review approved May 24, 2024; literature update through February 5, 2024; added HCPCS code L5969; policy statements unchanged.

06/01/25annual_review

Annual review approved May 12, 2025; literature update through February 5, 2025; policy statements unchanged.

04/01/26coding_update

Coding update added new HCPCS code L2221, effective April 1, 2026.

06/01/26annual_reviewLatest

Annual review approved May 11, 2026; policy updated with literature review through January 20, 2026; policy statements unchanged.